CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Quigley Jill M. Director | Grant or award · Stock Option (Right to Buy) | +53,000 | 53,000 | ||
| 2026-09-30 | Barry Richard President & CEO | Purchase | +100,000 | $0.92 | $92K | 1,337,964 |
| 2026-09-29 | Barry Richard President & CEO | Purchase | +206,813 | $0.90 | $186K | 1,237,964 |
| 2026-09-28 | Barry Richard President & CEO | Purchase | +93,091 | $0.84 | $78K | 1,031,151 |
| 2025-11-24 | Anderson Robert Eugene Jr Director | Purchase | +8,600 | $2.90 | $25K | 8,600 |
| 2025-11-20 | Barry Richard President & CEO | Purchase | +150,000 | $2.76 | $414K | 938,060 |
| 2025-11-19 | Barry Richard President & CEO | Purchase | +73,385 | $2.75 | $202K | 788,060 |
| 2025-10-21 | Bir Dawn Carter Director | Grant or award · Stock Option (Right to Buy) | +53,000 | 53,000 | ||
| 2025-09-30 | Cook Robert Christopher Chief Operating & Legal Office | Purchase | +13,725 | $2.91 | $40K | 13,725 |
| 2025-09-22 | Barry Richard President & CEO | Purchase | +7,172 | $2.28 | $16K | 714,675 |
| 2025-09-19 | Barry Richard President & CEO | Purchase | +400 | $2.25 | $900 | 660,595 |
| 2025-09-19 | Barry Richard President & CEO | Purchase | +46,908 | $2.29 | $107K | 707,503 |
| 2025-09-18 | Barry Richard President & CEO | Purchase | +5,400 | $2.13 | $12K | 474,962 |
| 2025-09-18 | Barry Richard President & CEO | Purchase | +185,233 | $2.24 | $415K | 660,195 |
| 2025-05-23 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 | ||
| 2025-05-23 | Anderson Robert Eugene Jr Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 | ||
| 2025-05-23 | Gravier Pierre Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 | ||
| 2025-05-23 | GUSSIN ROBERT Z Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 | ||
| 2025-05-23 | Nicaise Claude Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 | ||
| 2025-05-23 | O DONNELL MICHAEL J Director | Grant or award · Stock Option (Right to Buy) | +26,500 | 26,500 |
Page 1 of 17 · 324 trades